Repare Therapeutics Inc. (RPTX) Financials

RPTX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 253.9 million 41.8 million
2023-09-30 286.4 million 53.0 million
2023-06-30 301.6 million 56.2 million
2023-03-31 336.3 million 85.1 million

RPTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -28.6 million 6.4 million
2023-09-30 -32.9 million 6.4 million
2023-06-30 -35.4 million 6.3 million
2023-03-31 -32.3 million 6.1 million

RPTX Net Income

No data available :(

RPTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 223.6 million - 3.4 million
2023-09-30 250.1 million - 3.9 million
2023-06-30 280.7 million - 4.5 million
2023-03-31 314.1 million - 5.0 million

RPTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 42.1 million
2023-09-30 42.1 million
2023-06-30 42.1 million
2023-03-31 42.0 million

RPTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 398000 34.5 million 8.6 million 116000
2023-09-30 - 32.7 million 7.9 million -
2023-06-30 1.1 million 33.8 million 8.7 million -
2023-03-31 475000 31.8 million 8.5 million -

RPTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 13.0 million 506000
2023-09-30 2.2 million 1.0 million
2023-06-30 30.2 million 1.1 million
2023-03-31 5.7 million 982000

RPTX

Price: $3.45

52 week price:
3.02
13.85

Earnings Per Share: -2.23 USD

P/E Ratio: -3.64

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 108000

Market Capitalization: 164.5 million

Links: